Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case-control study (United States)

Cancer Causes and Control

Volumn 14, Issue 1, 2003, Pages 43-51

  Egan, Kathleen M ^a,g   Newcomb, Polly A ^b   Titus Ernstoff, Linda ^c   Trentham Dietz, Amy ^d   Mignone, Laura I ^e   Farin, Frederico ^f   Hunter, David J ^e  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF WISCONSIN   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Case control study; Risk factors

Indexed keywords

ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; DNA; UNCLASSIFIED DRUG;

ACETYLATOR PHENOTYPE; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MOUTH MUCOSA; POPULATION RESEARCH; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; TELEPHONE; UNITED STATES;

ADULT; AGED; ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; POPULATION SURVEILLANCE; SMOKING; UNITED STATES;

EID: 0037304825     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022517506689     Document Type: Article

References (41)

1. Baron J, Newcomb P, Longnecker M, et al. (1996) Cigarette smoking and breast cancer. Cancer Epidemiol Biomarkers Prev 5: 399-403.
2. Egan KM, Stampfer MJ, Hunter D, et al. (2002) Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology 13: 138-145.
3. McLaughlin JK, Blot WJ, Devesa SS, Fraumeni JF (1996) Renal cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention, 2nd edn. New York: Oxford University Press; pp. 1142-1155.
4. Silverman D, Dunn J, Hoover R, et al. (1994) Cigarette smoking and pancreas cancer: a case-control study based on direct interview. J Natl Cancer Inst 86: 1510-1516.
5. LaVecchia C, Franceschi S, De Carli A, Fasoli M, Gentile A, Tognoni G (1986) Cigarette smoking and the risk of cervical neoplasia. Am J Epidemiol 123: 22-29.
6. Petrakis N, Gruenke L, Beelen T, Castagnoli NJ, Craig J (1978) Nicotine in breast fluid of nonlactating women. Science 199: 303-304.
7. Petrakis N, Maack C, Lee R, Lyon M (1980) Mutagenic activity in nipple aspirates of human breast fluid. Cancer Res 40: 188-189.
8. Palmer J, Rosenberg L, Clarke E, et al. (1991) Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol 134: 1-13.
9. Marcus PM, Newman B, Millikan RC, Moorman PG, Baird DD, Qaqish B (2000) The associations of adolescent cigarette smoking, alcoholic beverage consumption, environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes Control 11: 271-278.
10. Russo J, Russo I (1980) Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res 40: 2677-2687.
11. Khuder SA, Mutgi AB, Nugent S (2001) Smoking and breast cancer: a meta-analysis. Rev Environ Health 16: 253-261.
12. DeBruin LS, Josephy PD (2002) Perspectives on the chemical etiology of breast cancer. Environ Health Perspect 110(Suppl. 1): 119-128.
13. Millikan R (2000) NAT1*10 and NAT1*11 polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 9: 217-219.
14. Huang CS, Chern HD, Shen CY, Hsu SM, Chang KJ (1999) Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence. Int J Cancer 82: 175-179.
15. Ambrosone CB, Freudenheim JL, Graham S, et al. (1996) Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA 276: 1494-1501.
16. Hunter D, Hankinson S, Hough H, et al. (1997) A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis 18: 2127-2132.
17. Millikan RC, Pittman GS, Newman B, et al. (1998) Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7: 371-378.
18. Morabia A, Bernstein MS, Bouchardy I, Kurtz J, Morris MA (2000) Breast cancer and active and passive smoking: the role of the N-acetyltransferase 2 genotype. Am J Epidemiol 152: 226-232.
19. Delfino RJ, Smith C, West JG, et al. (2000) Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. Pharmacogenetics 10: 461-469.
20. Krajinovic M, Ghadirian P, Richer C, et al. (2001) Genetic susceptibility to breast cancer in French-Canadians: role of carcinogen-metabolizing enzymes and gene-environment interactions. Int J Cancer 92: 220-225.
21. Agundez JA, Ladero JM, Olivera M, Abildua R, Roman JM, Benitez J (1995) Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients. Oncology 52: 7-11.
22. Deitz AC, Zheng W, Leff MA, et al. (2000) N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev 9: 905-910.
23. Newcomb P, Storer B, Longnecker M, et al. (1994) Lactation and a reduced risk of pre-menopausal breast cancer. N Engl J Med 330: 81-87.
24. Titus-Ernstoff L, Egan K, Newcomb P, et al. (1998) Exposure to breast milk in infancy and breast cancer risk in post-menopausal women. J Natl Cancer Inst 90: 921-924.
25. Garcia-Closas M, Egan KM, Abruzzo J, et al. (2001) Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev 10: 687-696.
26. Bell DA, Taylor JA, Butler MA, et al. (1993) Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14: 1689-1692.
27. Vatsis KP, Weber WW, Bell DA, et al. (1995) Nomenclature for N-acetyltransferases. Pharmacogeneties 5: 1-17.
28. Farin FM, Janssen P, Quigley S (2001) Genetic polymorphisms of microsomal and soluble epoxide hydrolase and the risk of Parkinson's disease. Pharmacogeneties 11: 703-708.
29. Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K (1995) Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4: 357-362.
30. Yang Q, Khoury MJ, Sun F, Flanders WD (1999) Case-only design to measure gene-gene interaction. Epidemiology 10: 167-170.
31. Thomas DC, Wine JS (2002) Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 11: 505-512.
32. Wacholder S, Rothman N, Caporaso N (2000) Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 92: 1151-1158.
33. Hein D (2000) N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. Toxicol Lett 112-113: 349-356.
34. Lang NP, Kadlubar FF (1991) Aromatic and heterocyclic amine metabolism and phenotyping in humans. Prog Clin Biol Res 372: 33-47.
35. Ambrosone CB, Freudenheim JL, Sinha R, et al. (1998) Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms. Int J Cancer 75: 825-830.
36. Gertig DM, Hankinson SE, Hough H, et al. (1999) N-acetyl transferase 2 genotypes, meat intake and breast cancer risk. Int J Cancer 80: 13-17.
37. Delfino RJ, Sinha R, Smith C, et al. (2000) Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype. Carcinogenesis 21: 607-615.
38. Sadrieh N, Davis CD, Snyderwine EG (1996) N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res 56: 2683-2687.
39. Williams JA, Stone EM, Fakis G, et al. (2000) Human mammary NAT and SULT enzymes metabolically activate N-hydroxylated heterocyclic amines but NAT enzyme activity is not influenced by NAT genotype. Proc Am Assoc Cancer Res 41: 551.
40. Williams JA (2001) Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression. Carcinogenesis 22: 209-214.
41. Zheng W, Deitz AC, Campbell DR, et al. (1999) N-acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8: 233-239.